DNP Alumni Brown, Affronti Write Article for APSHO COVID-19 Series
<p>Casey Brown, DNP '18, and Mary Lou Affronti, professor, recently published "<a href="https://www.apsho.org/page/COVID19_Diagnosis_and_Management_of_a_Patient_With_Glioblastoma_and_COVID-19">Diagnosis and Management of a Patient With Glioblastoma and COVID-19</a>" for the Advanced Practitioner Society For Hematology And Oncology (APSHO)'s APSHO Advance: Special COVID-19 Series.</p> <p> </p>
Casey Brown, DNP '18, and Mary Lou Affronti, professor, recently published "Diagnosis and Management of a Patient With Glioblastoma and COVID-19" for the Advanced Practitioner Society For Hematology And Oncology (APSHO)'s APSHO Advance: Special COVID-19 Series.
Abstract
A 66-year-old male with glioblastoma (GBM) on chemotherapy presents to the clinic with a 3-day history of nonspecific cough in the setting of seasonal allergies, subtle cognitive decline over the past 48 hours, and a low-grade temperature of 99.9°F. He is on dexamethasone for the treatment of brain edema secondary to his GBM.
This is a clinical presentation that advanced practitioners (APs) in oncology may experience. As an AP, one must know how to proceed in a pandemic such as COVID-19. Patients with cancer who are immunosuppressed secondary to their cancer and chemotherapy are at a higher risk for viral infections, including COVID-19 (Centers for Disease Control and Prevention [CDC], 2020). When a patient presents to the clinic with these symptoms, it is imperative that the AP identify and recognize the potential for COVID-19 infection.